| NUVB Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NUVB market cap history going back to 11/16/2020:
Also see: NUVB Shares Outstanding History and NUVB YTD Return |
As of 2/26/2026 Nuvation Bio has a market cap of 2.01 billion. Investors often follow the NUVB market cap history to compare the size of the company over time.
This page shows NUVB market capitalization trends over time, with 22 market cap datapoints presented, dating back to 11/16/2020.

| NUVB Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NUVB market cap history going back to 11/16/2020:
Also see: NUVB Shares Outstanding History and NUVB YTD Return |
| NUVB Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
NUVB Historical Market Cap: +63.54% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| NUVB Stock Price Chart |
| About Nuvation Bio Inc |
| Nuvation Bio is a clinical-stage biopharmaceutical company developing therapeutic candidates focused on treating patients with cancers. Co. is developing six wholly owned compounds that have resulted from its drug discovery and development programs, which include: NUV-422, a selective small molecule inhibitor of cyclin-dependent kinase; NUV-868, a BD2-selective oral small molecule bromodomain and extra-terminal inhibitor; NUV-569, an oral small molecule selective inhibitor of Wee1 kinase, a regulator of DNA damage repair; and a drug-drug conjugate platform, which is a therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates. We show 22 historical shares outstanding datapoints in our NUVB shares outstanding history coverage, used to compute NUVB market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NUVB market cap history over the course of time is important for investors interested in comparing NUVB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NUVB versus a peer is one thing; comparing NUVB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NUVB can fluctuate over the course of history. With this page we aim to empower investors researching NUVB by allowing them to research the NUVB market cap history. |
| NUVB Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| NUVB Share Performance |
| Market Cap Peers |
| Nuvation Bio (NUVB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
NUVL Market Cap History NUWE Market Cap History NVAX Market Cap History NVCT Market Cap History NVIV Market Cap History NVNO Market Cap History NVO Market Cap History NVOS Market Cap History NVRO Market Cap History NVST Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.